Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Diaceutics ( (GB:DXRX) ) just unveiled an update.
Diaceutics PLC has announced a change in its major holdings, with Danske Bank A/S crossing a voting rights threshold of 4.005652% as of December 16, 2024. This adjustment in holdings reflects Danske Bank’s increased influence in the company, suggesting potential strategic implications for Diaceutics and its stakeholders.
More about Diaceutics
Diaceutics PLC is a UK-based company operating in the healthcare industry. It specializes in precision testing solutions, supporting pharmaceutical firms with data analytics and services focused on optimizing patient testing and treatment pathways.
YTD Price Performance: 0%
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $128.1M
For an in-depth examination of DXRX stock, go to TipRanks’ Stock Analysis page.
